Work

Endostatin plus interferon-α2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents

Year: 2007

Type: article

Study design: Clinical Trial

Source: Melanoma Research

DOI: 10.1097/cmr.0b013e3281ad91a3

Authors: Stergios J. Moschos, Christine Odoux, Stephanie R. Land, Sanjiv Agarwala, David Friedland, Kirk M. Volker, Carolyn Sidor, Michael Wong, John M. Kirkwood

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, CASI Pharmaceuticals (United States), Roswell Park Comprehensive Cancer Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: University of Pittsburgh Clinical and Translational Science Institute, G8246462813

OpenAlex ID: W2093032187

FWCI: 1.459

Cites: 31

Cited by: 24

Related to: 10